MelindaSMerchantMDPhD
Pediatric Hematology & Oncology • New York, NYPediatric Oncology Branch, National Cancer Institute
Dr. Merchant is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1275 York Ave
New York, NY 10065Phone+1 646-227-3813
Education & Training
Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 1999 - 2002
Children's National HospitalResidency, Pediatrics, 1996 - 1999
University of Miami Leonard M. Miller School of MedicineClass of 1996
Certifications & Licensure
NY State Medical License 2005 - 2026- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- A Phase I Study of Ipilimumab (Anti-CTLA-4) in Children, Adolescents and Young Adults With Treatment Refractory Cancer Start of enrollment: 2007 Oct 01
- A Pilot Study of Genetically Engineered NY-ESO-1 Specific NY-ESO-1ᶜ²⁵⁹T in HLA-A2+ Patients With Synovial Sarcoma Start of enrollment: 2012 Sep 27
- Phase I Study of Ipilimumab (Anti-CTLA-4) in Children and Adolescents With Treatment-Resistant Cancer Start of enrollment: 2007 Oct 01
Publications & Presentations
PubMed
- 22 citationsImmune determinants of CAR-T cell expansion in solid tumor patients receiving GD2 CAR-T cell therapy.Sabina Kaczanowska, Tara Murty, Ahmad Alimadadi, Cristina F Contreras, Caroline Duault
Cancer Cell. 2024-01-08 - 29 citationsBrain exposure of the ATM inhibitor AZD1390 in humans-a positron emission tomography study.Aurelija Jucaite, Per Stenkrona, Zsolt Cselényi, Serena De Vita, Núria Buil-Bruna
Neuro-Oncology. 2021-04-12 - 9 citationsEvaluation of Combination Strategies for the A2AR Inhibitor AZD4635 Across Tumor Microenvironment Conditions via a Systems Pharmacology Model.Veronika Voronova, Kirill Peskov, Yuri Kosinsky, Gabriel Helmlinger, Lulu Chu
Frontiers in Immunology. 2021-03-02
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
